← Back to Search

Procedure

Phototherapy Garments for Psoriasis

N/A
Waitlist Available
Led By Joseph Jorizzo, M.D.
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adult participants ≥18 years of age
Participants who are diagnosed with mild-to-severe AA, PMLE, or psoriasis
Must not have
Participants currently using concomitant phototherapy
Participants without a sufficient command of the English language
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

Summary

This trial is looking at whether or not a new, more accessible phototherapy treatment is effective for psoriasis.

Who is the study for?
This trial is for adults over 18 living in the US with mild-to-severe Alopecia Areata, Polymorphous Light Eruption, or psoriasis. They must speak English well enough to understand the study requirements. People under 18, without these specific conditions, not living in the US, or using other phototherapy treatments cannot join.
What is being tested?
The trial is testing Lumiton yarn products (sleeve, hat, shirt) designed to provide a form of light therapy for skin conditions like psoriasis and alopecia. The goal is to see if wearing these clothes can help improve disease severity by mimicking beneficial effects of UV light treatment.
What are the potential side effects?
Since this trial involves clothing that emits light similar to phototherapy rather than drugs or invasive procedures, side effects may be minimal but could include skin irritation or sensitivity where the fabric touches.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I have been diagnosed with AA, PMLE, or psoriasis.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently undergoing phototherapy treatment.
Select...
I am not fluent in English.
Select...
I am under 18 years old.
Select...
I do not have mild to severe alopecia areata, polymorphic light eruption, or psoriasis.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Disease severity - PASI
Disease severity - SALT
Disease severity - photo

Trial Design

3Treatment groups
Active Control
Group I: PsoriasisActive Control1 Intervention
Psoriasis participants will be provided sleeves made from the Lumiton yarn to cover their arms. The participants will be instructed to wear the sleeves made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Group II: Alopecia AreataActive Control1 Intervention
Alopecia areata participants will be provided a hat made from the Lumiton yarn. The participants will be instructed to wear the hat made from Lumiton yarn daily for 12 weeks both indoors and outdoors.
Group III: Polymorphous Light EruptionActive Control1 Intervention
Polymorphous light eruption participants will be provided a shirt made from the Lumiton yarn. The participants will be instructed to wear the shirt made from Lumiton yarn daily for 12 weeks both indoors and outdoors.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,266 Previous Clinical Trials
1,013,694 Total Patients Enrolled
12 Trials studying Psoriasis
988 Patients Enrolled for Psoriasis
Joseph Jorizzo, M.D.Principal InvestigatorWake Forest University Health Sciences

Media Library

Phototherapy (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT05391178 — N/A
Psoriasis Research Study Groups: Psoriasis, Alopecia Areata, Polymorphous Light Eruption
Psoriasis Clinical Trial 2023: Phototherapy Highlights & Side Effects. Trial Name: NCT05391178 — N/A
Phototherapy (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05391178 — N/A
~2 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top